APREMILAST TEVA 10 mg, film-coated tablet. apremilast teva 20 mg, film-coated tablet. apremilast teva 30 mg, film-coated tablet 27 tablets
Active ingredients: Apremilast
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet27 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- APREMILAST TEVA 10 mg, comprimé pelliculé. APREMILAST TEVA 20 mg, comprimé pelliculé. APREMILAST TEVA 30 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé et comprimé pelliculé pelliculé
- Route of administration
- orale
- Presentation description
- plaquettes PVC/PCTFE/PVC-Aluminium de 27 comprimés pelliculés (4 comprimés de 10 mg + 4 comprimés de 20 mg + 19 comprimés de 30 mg)
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Jan 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63675413CIP73029861CIP133400930298619Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| APRÉMILASTcomprimé 10 mg | 10 mg · un comprimé | SA |
| APRÉMILASTcomprimé 20 mg | 20 mg · un comprimé | SA |
| APRÉMILASTcomprimé 30 mg | 30,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.